New peer-reviewed research published in JCI Insight (2023) demonstrates that the standardized ginger extract Ginactiv® modulates neutrophil hyperactivity associated with autoimmune and inflammatory disease mechanisms.

Key Findings

The study demonstrates that oral Ginactiv® intake:

• Suppresses NET formation (NETosis)

• Targets immune overactivation associated with inflammaging

• Boosts neutrophil cAMP levels via natural PDE inhibition

• Reduces thrombosis and autoantibody production in autoimmune models

• Reduces NET formation in healthy human neutrophils in response to disease-relevant stimuli after 7 days of intake

Ginactiv® opens formulation opportunities to align with immune resilience, vascular health, and healthy aging applications.

Explore how Ginactiv® can elevate your next immune innovation.

Contact: info@aureabiolabs.com